Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) Cost of Revenue (2017 - 2025)

Historic Cost of Revenue for Selectis Health (GBCS) over the last 9 years, with Q3 2025 value amounting to $8.5 million.

  • Selectis Health's Cost of Revenue rose 1248.42% to $8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.6 million, marking a year-over-year increase of 790.48%. This contributed to the annual value of $30.4 million for FY2024, which is 324.16% down from last year.
  • As of Q3 2025, Selectis Health's Cost of Revenue stood at $8.5 million, which was up 1248.42% from $8.2 million recorded in Q2 2025.
  • In the past 5 years, Selectis Health's Cost of Revenue registered a high of $8.9 million during Q4 2021, and its lowest value of $3.5 million during Q1 2021.
  • In the last 5 years, Selectis Health's Cost of Revenue had a median value of $7.6 million in 2024 and averaged $7.3 million.
  • As far as peak fluctuations go, Selectis Health's Cost of Revenue surged by 9640.15% in 2022, and later tumbled by 1184.66% in 2024.
  • Selectis Health's Cost of Revenue (Quarter) stood at $8.9 million in 2021, then fell by 2.18% to $8.7 million in 2022, then decreased by 10.66% to $7.7 million in 2023, then rose by 1.61% to $7.9 million in 2024, then grew by 8.29% to $8.5 million in 2025.
  • Its Cost of Revenue stands at $8.5 million for Q3 2025, versus $8.2 million for Q2 2025 and $8.1 million for Q1 2025.